Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in Perinatology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.semperi.2015.11.007PMID 26718445PMCID PMC4826755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical implementation of NIPT – technical and biological challenges

  2016cited by this paper
• It's complicated – Factors predicting decisional conflict in prenatal diagnostic testing

  2016cited by this paper
• Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening

  2015influential reference
• Early fetal anatomy screening: who, what, when and why?

  2015cited by this paper
• Patient-Centered Prenatal Counseling: Aligning Obstetric Healthcare Professionals With Needs of Pregnant Women

  2015cited by this paper
• Current controversies in prenatal diagnosis 3: the ethical and counseling implications of new genomic technologies: all pregnant women should be offered prenatal diagnostic genome‐wide testing for prenatally identified fetal congenital anomalies

  2015cited by this paper
• Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing

  2015cited by this paper
• Whole‐genome array as a first‐line cytogenetic test in prenatal diagnosis

  2015cited by this paper
• A first look at women's perspectives on noninvasive prenatal testing to detect sex chromosome aneuploidies and microdeletion syndromes

  2015cited by this paper
• Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond

  2015cited by this paper
• Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting

  2015cited by this paper
• Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening

  2015cited by this paper
• Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing.

  2015cited by this paper
• Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

  2015influential reference
• Printing Unrealistic Expectations: A Closer Look at Newspaper Representations of Noninvasive Prenatal Testing

  2015cited by this paper
• Cell free DNA testing-interpretation of results using an online calculator.

  2015cited by this paper
• Carrier Screening for Spinal Muscular Atrophy Among U.S. In Vitro Fertilization Patients [289]

  2015cited by this paper
• Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Feta

  2015influential reference
• Evaluation of Patient Education Materials: The Example of Circulating cell free DNA Testing for Aneuploidy

  2015influential reference
• #36: Prenatal aneuploidy screening using cell-free DNA.

  2015cited by this paper
• Prenatal aneuploidy screening using cell free DNA.

  2015cited by this paper
• Uptake of noninvasive prenatal testing at a large academic referral center.

  2014cited by this paper
• The impact of chromosomal microarray on clinical management: a retrospective analysis

  2014cited by this paper
• An Exploration of Genetic Counselors’ Needs and Experiences with Prenatal Chromosomal Microarray Testing

  2014cited by this paper
• Innovations in prenatal genetic testing beyond the fetal karyotype.

  2014cited by this paper
• Genetic Counselors’ Experience with Cell-Free Fetal DNA Testing as a Prenatal Screening Option for Aneuploidy

  2014cited by this paper
• Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases

  2014cited by this paper
• Evaluation of a Novel Electronic Genetic Screening and Clinical Decision Support Tool in Prenatal Clinical Settings

  2014cited by this paper
• A New Model for Providing Cell-Free DNA and Risk Assessment for Chromosome Abnormalities in a Public Hospital Setting

  2014cited by this paper
• Molecular Testing for Cystic Fibrosis Carrier Status Practice Guidelines: Recommendations of the National Society of Genetic Counselors

  2014cited by this paper
• Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray

  2014cited by this paper
• Counseling Challenges with Variants of Uncertain Significance and Incidental Findings in Prenatal Genetic Screening and Diagnosis

  2014cited by this paper
• Measuring informed choice in population-based reproductive genetic screening: a systematic review

  2014cited by this paper
• Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States.

  2014cited by this paper
• Chromosomal Microarray Analysis and Prenatal Diagnosis

  2014cited by this paper
• What women want: lead considerations for current and future applications of noninvasive prenatal testing in prenatal care.

  2014cited by this paper
• Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results

  2014cited by this paper
• Clinical Perspective of Cell-Free DNA Testing for Fetal Aneuploidies

  2014cited by this paper
• Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges.

  2014cited by this paper
• The case for universal prenatal genetic counseling.

  2014cited by this paper
• Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial.

  2014cited by this paper
• Positive predictive value of cell free DNA analysis.

  2014cited by this paper
• Noninvasive prenatal testing: need for informed enthusiasm.

  2014cited by this paper
• Controversies in prenatal diagnosis 3: should everyone undergoing invasive testing have a microarray?

  2014cited by this paper
• Chromosome Abnormalities Detected by Current Prenatal Screening and Noninvasive Prenatal Testing

  2014cited by this paper
• NIPT: current utilization and implications for the future of prenatal genetic counseling

  2014cited by this paper
• Non‐invasive prenatal testing for fetal aneuploidy: charting the course from clinical validity to clinical utility

  2013cited by this paper
• Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease

  2013cited by this paper
• The clinical implementation of non‐invasive prenatal diagnosis for single‐gene disorders: challenges and progress made

  2013cited by this paper
• ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing

  2013cited by this paper
• Noninvasive prenatal testing: the paradigm is shifting rapidly

  2013cited by this paper
• Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

  2013cited by this paper
• ACMG statement on noninvasive prenatal screening for fetal aneuploidy

  2013cited by this paper
• Noninvasive Prenatal Testing/Noninvasive Prenatal Diagnosis: the Position of the National Society of Genetic Counselors

  2013cited by this paper
• ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics

  2013cited by this paper
• Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis.

  2013cited by this paper
• Non‐invasive prenatal testing for aneuploidy: current status and future prospects

  2013cited by this paper
• Improving knowledge about prenatal screening options: can group education make a difference?

  2013cited by this paper
• Considering the cost of expanded carrier screening panels

  2013cited by this paper
• Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing

  2013cited by this paper
• ACMG position statement on prenatal/preconception expanded carrier screening

  2013cited by this paper
• Expanded carrier screening panels—does bigger mean better?

  2013cited by this paper
• Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?

  2013cited by this paper
• A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors

  2013cited by this paper
• Presented Abstracts from the Thirty Second Annual Education Conference of the National Society of Genetic Counselors (Anaheim, CA, October 2013)

  2013cited by this paper
• Noninvasive prenatal testing: limitations and unanswered questions

  2013cited by this paper
• Microarrays as a diagnostic tool in prenatal screening strategies: ethical reflection

  2013cited by this paper
• Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint.

  2013cited by this paper
• Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy.

  2012cited by this paper
• Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing

  2012cited by this paper
• Genetic Counseling and Testing for FMR1 Gene Mutations: Practice Guidelines of the National Society of Genetic Counselors

  2012cited by this paper
• Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing

  2012cited by this paper
• “What does it mean?”: Uncertainties in understanding results of chromosomal microarray testing

  2012cited by this paper
• An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals

  2012cited by this paper
• Cell-free fetal DNA testing: who is driving implementation?

  2012cited by this paper
• Women’s experiences receiving abnormal prenatal chromosomal microarray testing results

  2012influential reference
• Chromosomal microarray versus karyotyping for prenatal diagnosis.

  2012cited by this paper
• Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks

  2011cited by this paper
• Risk and uncertainty: Shifting decision making for aneuploidy screening to the first trimester of pregnancy

  2011cited by this paper
• ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.

  2011cited by this paper
• The dangers of including nonclassical cystic fibrosis variants in population-based screening panels: p.L997F, further genotype/phenotype correlation data

  2011cited by this paper
• Can We Make Assumptions About the Psychosocial Impact of Living as a Carrier, Based on Studies Assessing the Effects of Carrier Testing?

  2011cited by this paper
• Expanded carrier screening and the law of unintended consequences: From cystic fibrosis to fragile X

  2011cited by this paper
• Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing

  2011cited by this paper
• Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011

  2011cited by this paper
• Sixteen years of prenatal consultations for the N370S/N370S Gaucher disease genotype: What have we learned?

  2010cited by this paper
• ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.

  2010cited by this paper
• Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

  2010cited by this paper
• Practical and ethical considerations of noninvasive prenatal diagnosis.

  2009cited by this paper
• Challenging the rhetoric of choice in prenatal screening.

  2009cited by this paper
• ACOG committee opinion No. 432: spinal muscular atrophy.

  2009cited by this paper
• ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.

  2009cited by this paper
• Carrier screening for spinal muscular atrophy

  2008cited by this paper
• ACOG Committee Opinion No. 410: Ethical issues in genetic testing.

  2008cited by this paper
• ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy.

  2007cited by this paper
• ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.

  2007cited by this paper
• [Increased nuchal translucency with normal karyotype].

  2007cited by this paper
• Pregnancy loss rates after midtrimester amniocentesis.

  2007cited by this paper
• What do Patients Prefer: Informed Consent Models for Genetic Carrier Testing

  2007cited by this paper
• Pregnancy Loss Rates After Midtrimester Amniocentesis

  2006cited by this paper

• The Meaning of Screening: Exploring user experience of an aneuploidy screening educational game

  2026cites this paper
• Genetic counselors’ perspectives on the expanded use of non-invasive prenatal testing

  2026cites this paper
• Assessing the Ethical Considerations in the Era of Advanced Prenatal Testing and Genetic Counselling – Clinicians’ Perspective

  2025cites this paper
• Pediatric nephrologists’ perspectives and clinical practices related to genetic testing and education

  2024cites this paper
• Genetic counselling in the era of next generation sequencing.

  2024cites this paper
• Asesoramiento genético en la era de la secuenciación masiva

  2024cites this paper
• The Feasibility and Impact of a Computer-Aided Genetics Education Module in an Obstetrics Clinic: A Randomized Controlled Trial

  2023cites this paper
• Prenatal diagnosis after high chance non-invasive prenatal testing for trisomies 21, 18 and 13, chorionic villus sampling or amniocentesis? – Experience at a district general hospital in the United Kingdom

  2023cites this paper
• Evaluation of pre-test counselling offered for non-invasive prenatal testing (NIPT) as a primary screening tool

  2023cites this paper
• An Indian Child with CONDSIAS Due to a Novel Variant in ADPRHL2 Gene

  2022cites this paper
• Latinx individuals’ knowledge of, preferences for, and experiences with prenatal genetic testing: a scoping review

  2022cites this paper
• Counselling and education for prenatal screening and diagnostic tests for pregnant women: Randomized controlled trial.

  2021cites this paper
• Fetal Morph Functional Diagnosis

  2021cites this paper
• 20-year experience on prenatal diagnosis in a reference university medical genetics center in Turkey

  2021cites this paper
• To what extent do decision aids for prenatal screening and diagnosis address involvement of partners in decision-making? - An environmental scan.

  2021cites this paper
• Prenatal Diagnosis of Chromosomal Abnormalities: From Karyotype to Microarray

  2021cites this paper
• Interventions aiming to improve informed decision on prenatal screening and testing: A scoping review of the literature

  2021cites this paper
• Experiences of non‐invasive prenatal screening: A survey study

  2021cites this paper
• Haemoglobinopathies: Genetic Services in India

  2021cites this paper
• Newer variants of progressive familial intrahepatic cholestasis

  2021cites this paper
• Fetal Anomaly and Genetic Counseling

  2020cites this paper
• Evaluation of the results of patients who applied to the Çukurova University, Medical Genetics Department for prenatal diagnosis and determination of genetic counseling principles

  2020cites this paper
• Application Research of Precision Medical Model Based on Big Data in Primary Health Care in China

  2020cites this paper
• Prenatal Genetic Screening and Potential Complicity in Abortion: Considerations for Catholic Health Care

  2020cites this paper
• Exome and Genome Sequencing

  2019cites this paper
• Beyond the Brochure: Innovations in Clinical Counseling Practices for Prenatal Genetic Testing Options

  2019influential citation
• Next-Generation Sequencing for Gene Panels and Clinical Exomes

  2019cites this paper
• Prenatal Genetic Counseling in Congenital Anomalies

  2018influential citation
• Exome and genome sequencing in reproductive medicine.

  2018cites this paper
• Prenatal diagnosis by chromosomal microarray analysis.

  2018cites this paper
• Getting to the Heart of the Matter: Lysosomal Storage Diseases That Manifest a Cardiac Phenotype

  2018cites this paper
• Mucopolysaccharidosis and Adulthood: Genetics, Inheritance, and Reproductive Options

  2018cites this paper
• Knowledge and Attitudes After Using Videos to Educate a Non-Clinical Cohort About Prenatal Cell-Free DNA Screening

  2017cites this paper
• “They Can't Find Anything Wrong with Him, Yet”: Mothers’ experiences of parenting an infant with a prenatally diagnosed copy number variant (CNV)

  2017cites this paper
• The first antenatal diagnosis of KBG syndrome: a microdeletion at chromosome 16q24.2q24.3 containing multiple genes including ANKRD11 associated with the disorder

  2017cites this paper
• Genetic counselling, patient education, and informed decision-making in the genomic era.

  2017cites this paper
• The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis.

  2017cites this paper
• Development and Evaluation of a Simulation-Based, Medical Student Teaching Session for Communicating Bad News and Uncertainty Along the Obstetric-Neonatal Continuum

  2017cites this paper
• PRECISION REPRODUCTIVE MEDICINE: THE DAWN OF PRE-IVF GENETIC SCREENING

  2016influential citation
• Pros and cons of implementing a carrier genetic test in an infertility practice

  2016cites this paper
• Non-invasive prenatal testing for aneuploidy screening : the state-ofthe-art Testes pré-natais não invasivos para rastreio de aneuploidias :

  year unknowncites this paper